Analyst firms · Daiwa · ABBV
Daiwa ABBV price target and rating history
AbbVie Inc. (ABBV) · Health Care
Daiwa rates AbbVie Inc. (ABBV) Outperform with a $214 price target, as of its latest action on Aug 7, 2025. It has published 3 rating actions on ABBV since May 2022, including 1 upgrade and 2 downgrades. Across 8 firms with a ABBV price target in the last 12 months, the median target is $263.50.
- Current rating
- Outperform
- Price target
- $214
- Median target, all firms
- $263.50
- Actions on ABBV
- 3
Daiwa price target on ABBV
Every Daiwa rating on ABBV
- Aug 7, 2025
- Dec 5, 2024
- May 6, 2022
How other firms rate ABBV
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wolfe Research | Outperform | $300 | Aug 13, 2026 |
| Erste Group | Buy | Aug 5, 2026 | |
| BofA Securities | Buy | $234 | Apr 30, 2026 |
| Canaccord Genuity | Buy | $262 | Apr 21, 2026 |
| RBC Capital Markets | Outperform | $260 | Feb 25, 2026 |
| Barclays | Overweight | $275 | Feb 20, 2026 |
| UBS | Neutral | $240 | Jan 7, 2026 |
| HSBC | Buy | $265 | Dec 10, 2025 |
| Scotiabank | Sector Outperform | $280 | Nov 13, 2025 |
Questions about Daiwa and ABBV
- What is Daiwa's price target for ABBV?
- Daiwa's latest stated price target for AbbVie Inc. (ABBV) is $214, from its action on Aug 7, 2025.
- What is Daiwa's rating on ABBV?
- Daiwa rates ABBV Outperform, a bullish rating, as of Aug 7, 2025.
- When did Daiwa last change its view on ABBV?
- On Aug 7, 2025, Daiwa upgrades to Outperform from Neutral, price target $214.
- How does Daiwa's ABBV target compare with other analysts?
- Across 8 firms with a ABBV price target in the last 12 months, the median target is $263.50.
More ABBV rating histories
All Daiwa ratingsABBV news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.